ReviewTranslational lung cancer research2020

Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies.

Alessandro Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.